Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial crawled date : 2021 - 06 - 23 save search
BioVie Receives FDA Guidance for Phase 3 Clinical Trial of BIV201 in HRS-AKICompany Planning a Potentially Pivotal Study in This Life-Threatening Complication of Ascites
Published: 2021-06-23 (Crawled : 23:00) - biospace.com/
BIVI | $0.4874 -0.21% -0.21% 490K
|
Health Technology
|
| O: 0.65%
H: 2.05%
C: -0.88%
fda potential phase 3 trial
AGTC to Host Conference Call on June 24 at 8:00 AM ET to Discuss Achromatopsia 12-Month Data in its Ongoing CNGB3 and CNGA3 Phase 1/2 Clinical Trials
Published: 2021-06-23 (Crawled : 21:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: 0.92%
H: 2.73%
C: 2.27%
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 2.17%
H: 0.0%
C: -1.42%
ongoing clinical trials phase 1 trial conference
AGTC to Host Conference Call to Discuss Achromatopsia 12-Month Data in its Ongoing Phase 1/2 Clinical Trials
Published: 2021-06-23 (Crawled : 21:00) - agtc.com
OTIC | $0.077
|
Health Technology
|
| O: -0.89%
H: 3.14%
C: 1.35%
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 5.28%
H: 4.56%
C: -1.59%
ongoing clinical trials phase 1 trial conference phase 2 phase 3
Rubius Therapeutics Announces First Patient Dosed with RTX-240 in Combination with KEYTRUDA® (pembrolizumab) in Ongoing Phase 1/2 Clinical Trial for the Treatment of Advanced Solid Tumors
Published: 2021-06-23 (Crawled : 21:00) - biospace.com/
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: -0.81%
H: 2.24%
C: 1.02%
treatment solid tumors ongoing phase 1 trial phase 2 keytruda
Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer Following FDA Review
Published: 2021-06-23 (Crawled : 18:00) - biospace.com/
GNPX | $2.2194 -2.31% 38K
|
Health Technology
|
| O: 5.45%
H: 11.78%
C: 6.9%
fda lung cancer phase 1 gene therapy therapy cancer trial
PureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
Published: 2021-06-23 (Crawled : 18:00) - biospace.com/
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 1.44%
H: 2.4%
C: -5.38%
phase 1 results trial phase 1b phase 2b
GT Biopharma Announces Interim GTB-3550 Trike™ Monotherapy Clinical Trial Results At 2021 Raymond James Human Health Innovation Conference
Published: 2021-06-23 (Crawled : 18:00) - biospace.com/
GTBP | $3.8001 1.3% 5.9K
|
Manufacturing
|
| O: 0.13%
H: 7.29%
C: -1.29%
biopharma therapy results trial trial results conference
Medtronic Announces Real-World Data on InPen™ and Extended Infusion Set* Pivotal Trial Data at the American Diabetes Association 81st Scientific Sessions
Published: 2021-06-23 (Crawled : 18:00) - biospace.com/
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 0.01%
H: 0.14%
C: -0.99%
diabetes trial
Join Science 37 for a Panel of Health Industry Leaders Exploring “Decentralized Clinical Trials and the Empowered Patient Trial Experience” at Reuters Webinar
Published: 2021-06-23 (Crawled : 17:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 0.02%
C: -1.01%
clinical trials trial
DURECT Corporation Presents Additional Clinical Data from DUR-928 Phase 1b Trial in NASH and Phase 1 Trial in Hepatic Impairment at the International Liver Conference 2021 (EASL)
Published: 2021-06-23 (Crawled : 16:00) - biospace.com/
DRRX | $0.9019 -0.89% -0.9% 110K
|
Health Technology
|
| O: 0.59%
H: 1.18%
C: -1.18%
phase 1 nash liver trial conference phase 2 phase 1b hepatitis phase 2b
Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial
Published: 2021-06-23 (Crawled : 16:00) - biospace.com/
ATHE | $2.04 -4.67% -4.9% 54K
|
Health Technology
|
| O: 7.69%
H: 0.71%
C: -6.43%
phase 2 europe trial ath434
JanOne Readies Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial Sites
Published: 2021-06-23 (Crawled : 14:15) - janone.com
JAN | $3.94 6.49% 6.09% 160K
|
Industrial Services
|
| O: -2.04%
H: 11.84%
C: -3.51%
phase 2 distribution phase 2b trial
Insights on the Industrial Ethernet Global Market to 2027 - Featuring Huawei Technologies, ABB and Belden Among Others
Published: 2021-06-23 (Crawled : 14:00) - prnewswire.com
ROK | $269.96 -1.29% 0.0% 1.2M
|
Producer Manufacturing
|
| O: 0.29%
H: 1.23%
C: -0.07%
CSCO | $48.33 0.46% 0.46% 20M
|
Technology Services
|
| O: 0.02%
H: 0.04%
C: -0.96%
trial
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations
Published: 2021-06-23 (Crawled : 14:00) - prnewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 1.06%
H: 3.73%
C: 1.53%
trial
Medicenna Announces Submission of Clinical Trial Application in Australia for a Phase 1/2 Study of MDNA11
Published: 2021-06-23 (Crawled : 13:00) - globenewswire.com
MDNA | $0.157 -0.32% 1.3M
|
Health Technology
|
| O: 2.68%
H: 0.0%
C: -9.4%
phase 1 trial submission phase 2 phase 3 application
XBiotech Announces First Patient Enrolled in Clinical Trial Evaluating XB2001 for the Treatment of Pancreatic Cancer
Published: 2021-06-23 (Crawled : 13:00) - globenewswire.com
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: -0.12%
H: 1.73%
C: 1.17%
treatment cancer biotech iot trial pancreatic pancreas enroll
Cocrystal Pharma Completes IND-enabling Studies with CC-42344 for the Treatment of Seasonal and Pandemic Influenza A, Plans to initiate a Phase 1 Trial in the Third Quarter
Published: 2021-06-23 (Crawled : 12:15) - globenewswire.com
COCP | $1.495 -1.39% 7.6K
|
Health Technology
|
| O: 0.0%
H: 2.67%
C: 2.29%
treatment phase 1 influenza trial cc-42344
Glycomine Closes $68 Million Series B to Advance into Clinical Trials a Novel Treatment for PMM2-CDG, a Rare Glycosylation Disease
Published: 2021-06-23 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 0.02%
C: -1.01%
disease treatment clinical trials trial rare
Editas Medicine Announces Enrollment of the First Pediatric Cohort in the BRILLIANCE Clinical Trial of EDIT-101 for the Treatment of LCA10 Following IDMC Endorsement
Published: 2021-06-23 (Crawled : 12:00) - biospace.com/
EDIT | $5.5 -0.9% -0.91% 2.3M
|
Health Technology
|
| O: 0.0%
H: 5.03%
C: 3.87%
treatment trial enroll
Clovis Oncology Announces LuMIERE Clinical Trial Evaluating Novel Peptide-Targeted Radionuclide Therapy FAP-2286 Now Open for Enrollment
Published: 2021-06-23 (Crawled : 12:00) - biospace.com/
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.34%
H: 5.42%
C: 4.58%
therapy trial enroll
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.